cpx-351
Showing 26 - 30 of 30
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States
Completed
- Acute Myeloid Leukemia (AML)
- +2 more
- CPX-351
-
Indianapolis, Indiana
- +4 more
Oct 23, 2017
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (CPX-351)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- CPX-351
-
New York, New YorkWeill Cornell Medical College
Jan 12, 2018
Secondary AML Trial in United States (CPX-351)
Approved for marketing
- Secondary AML
- CPX-351
-
Los Angeles, California
- +5 more
Aug 17, 2017
Acute Myeloid Leukemia Trial in Worldwide (CPX-351, Intensive Salvage Therapy)
Completed
- Acute Myeloid Leukemia
- CPX-351
- Intensive Salvage Therapy
-
Tucson, Arizona
- +41 more
Oct 20, 2017